Arlington Partners LLC Novo Nordisk A S Transaction History

Arlington Partners LLC

$241 Million
Q3 2024

A detailed history of Arlington Partners LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Arlington Partners LLC holds 29,412 shares of NVO stock, worth $3.1 Million. This represents 1.45% of its overall portfolio holdings.

Number of Shares

29,412

Previous 23,477 25.28%

Holding current value

$3.1 Million

Previous $3.35 Million 4.51%

% of portfolio

1.45%

Previous 1.77%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$119.07 - $145.42 $706,680 - $863,067	5,935 Added 25.28%	29,412 $3.5 Million
Q2 2024 Aug 01, 2024	SELL	$122.71 - $146.91 $451,572 - $540,628	-3,680 Reduced 13.55%	23,477 $3.35 Million
Q1 2024 Apr 16, 2024	SELL	$102.11 - $135.92 $308,167 - $410,206	-3,018 Reduced 10.0%	27,157 $3.49 Million
Q4 2023 Jan 24, 2024	SELL	$87.78 - $105.45 $103,317 - $124,114	-1,177 Reduced 3.75%	30,175 $3.12 Million
Q3 2023 Oct 24, 2023	BUY	$90.94 - $199.54 $1.6 Million - $3.52 Million	17,641 Added 128.66%	31,352 $2.85 Million
Q1 2023 Apr 26, 2023	SELL	$132.34 - $159.14 $830,433 - $998,603	-6,275 Reduced 31.4%	13,711 $2.18 Million
Q3 2022 Oct 28, 2022	BUY	$95.28 - $116.93 $30,775 - $37,768	323 Added 1.64%	19,986 $1.99 Million
Q2 2022 Jul 25, 2022	SELL	$103.24 - $121.81 $515,374 - $608,075	-4,992 Reduced 20.25%	19,663 $2.19 Million
Q1 2022 Apr 14, 2022	SELL	$93.1 - $112.54 $342,235 - $413,697	-3,676 Reduced 12.98%	24,655 $2.74 Million
Q4 2021 Jan 18, 2022	SELL	$95.88 - $117.08 $379,397 - $463,285	-3,957 Reduced 12.26%	28,331 $3.17 Million
Q3 2021 Oct 15, 2021	SELL	$84.42 - $106.62 $898,566 - $1.13 Million	-10,644 Reduced 24.79%	32,288 $3.1 Million
Q2 2021 Jul 07, 2021	BUY	$67.66 - $84.76 $67,862 - $85,014	1,003 Added 2.39%	42,932 $3.6 Million
Q1 2021 Apr 19, 2021	BUY	$67.06 - $75.82 $434,884 - $491,692	6,485 Added 18.3%	41,929 $2.83 Million
Q4 2020 Jan 13, 2021	BUY	$63.89 - $73.8 $26,706 - $30,848	418 Added 1.19%	35,444 $2.48 Million
Q2 2020 Jul 13, 2020	SELL	$58.54 - $67.94 $206,353 - $239,488	-3,525 Reduced 9.14%	35,026 $2.29 Million
Q1 2020 Apr 13, 2020	BUY	$49.46 - $64.78 $1.53 Million - $2 Million	30,866 Added 401.64%	38,551 $2.32 Million
Q4 2019 Jan 16, 2020	BUY	$49.86 - $58.26 $85,759 - $100,207	1,720 Added 28.83%	7,685 $445,000
Q3 2019 Oct 18, 2019	SELL	$47.54 - $53.43 $2.01 Million - $2.25 Million	-42,185 Reduced 87.61%	5,965 $308,000
Q2 2019 Jul 10, 2019	BUY	$46.79 - $52.47 $2.02 Million - $2.27 Million	43,190 Added 870.77%	48,150 $2.46 Million
Q1 2019 Apr 05, 2019	SELL	$46.36 - $52.63 $1.07 Million - $1.21 Million	-22,990 Reduced 82.25%	4,960 $259,000
Q4 2018 Jan 10, 2019	BUY	$41.54 - $47.25 $28,662 - $32,602	690 Added 2.53%	27,950 $1.29 Million
Q3 2018 Oct 23, 2018	BUY	$46.76 - $51.24 $17,768 - $19,471	380 Added 1.41%	27,260 $1.29 Million
Q1 2018 May 07, 2018	BUY	$48.49 - $58.14 $93,343 - $111,919	1,925 Added 7.71%	26,880 $1.32 Million
Q4 2017 Jan 29, 2018	BUY	$47.53 - $53.73 $1.19 Million - $1.34 Million	24,955	24,955 $1.34 Million

Others Institutions Holding NVO

# of Institutions

1,952

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $238B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arlington Partners LLC with notifications on news.

Account

Arlington Partners LLC Novo Nordisk A S Transaction History